Association between Cardiovascular Disease with Smokeless Tobacco Consumption and Smoking
Abstract
cardiovascular risks, for example, glucose intolerance and low serum levels of high-density lipoprotein cholesterol (HDLc). These risks are also exposed to people who are passively exposed to the smoke, thereby putting them also at a risk for CVDs.
Keywords: cardiovascular disease (CVD) risk, smoking, smokeless tobacco, tobacco chewing
Full Text:
PDFReferences
Gupta B.K., Kaushik A., Panwar R.B., et al. Cardiovascular risk factors in tobacco-chewers: a controlled study, J Assoc Physicians India. 007; 55: 27– 31p.
Gupta R. Recent trends in coronary heart disease epidemiology in India, Indian Heart J. 2008; 60(2 Suppl B): B4–18p.
Norberg M., Stenlund H., Lindahl B., et al. Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep’s clothing? Scand J Public Health. 2006; 34(6): 576–83p.
Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update, J Am Coll Cardiol. 2004; 43(10):
–7.
Baker F., Ainsworth S.R., Dye J.T., et al. Health risks associated with cigar smoking, J Am Med Assoc. 2000; 284(6): 735–40p.
Barger A.C., Beeuwkes R. 3rd, Lainey L.L., et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis, N Engl J Med. 1984; 310(3): 175–7p.
Barua R.S., Ambrose J.A., Srivastava S., et al. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide
biosynthesis and upregulation of endothelial nitric oxide synthase: an in
vitro demonstration in human coronary artery endothelial cells, Circulation. 2003; 107(18): 2342–7p.
Beckman J.A., Liao J.K, Hurley S., et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein, Circ Res. 2004; 95(2): 217–23p.
Benowitz N.L., Fitzgerald G.A., Wilson M., et al. Nicotine effects on
eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking, J Am Coll Cardiol. 1993; 22(4): 1159–67p.
Centers for Disease Control and Prevention. Smoking-attributable
mortality, years of potential life lost, and productivity losses—United
States, 2000–2004, Morbid Mortal Wkly Rep. 2008; 57(45): 1226–8p.
Chisolm G.M., Steinberg D. The oxidative modification hypothesis of
atherogenesis: an overview, Free Radic Biol Med. 2000; 28(12): 1815–
p.
Chung T.W., Tyan Y.C., Hsieh J.H., et al. Shear stress-induced aggregation of oxidized platelets, Thromb Res. 2002; 105(4): 325–9p.
Czernin J., Waldherr C. Cigarette smoking and coronary blood flow,
Prog Cardiovasc Dis. 2003; 45(5): 395–404p.
Dinno A., Glantz S. Clean indoor air laws immediately reduce heart attacks, Prev Med. 2007; 45(1): 9–11p.
Djoussé L., Myers R.H., Province M.A., et al. Influence of polipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study, Stroke. 2002; 33(5): 1357–61p.
Eliasson B. Cigarette smoking and diabetes, Prog Cardiovasc Dis. 2003; 45(5): 405–13p.
Eliasson B., Hjalmarson A., Kruse E., Landfeldt B., et al. Effect of smoking reduction and cessation on cardiovascular risk factors, Nicotine
Tobacco Res. 2001; 3(3): 249–55p.
Fiore M.C., Bailey W.C., Cohen S.J., et al. Treating Tobacco Use and
Dependence, Clinical Practice Guideline. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2000.
Franzoni F., Quiñones-Galvan A., Regoli F., et al. A comparative study of the in vitro antioxidant activity of statins, Int J Cardiol. 2003; 90(2–3): 317–21p.
Heeschen C., Weis M., Cooke J.P. Nicotine promotes arteriogenesis, J Am Coll Cardiol. 2003; 41(3): 489–96p.
DOI: https://doi.org/10.37628/ijcn.v1i1.160
Refbacks
- There are currently no refbacks.